Banner for leaf pages 2


Also known as Omnicef and Omnicef Omni-Pac

Cefdinir is a third generation oral cephalosporin antibiotic. It was discovered by Fujisawa Pharmaceutical Co., Ltd. "Fujisawa" (now Astellas) and introduced in 1991 under the brand name Cefzon. Warner-Lambert licensed this cephalosporin, cefdinir, for marketing in US from Fujisawa, Japan. Abbott obtained U.S. marketing rights to Omnicef (Cefdinir) in December 1998 through an agreement with Warner-Lambert Company. It was approved by FDA on Dec 4, 1997. It is available in US as Omnicef by Abbott Laboratories and in India as Cednir by Abbott and Cefdiel by Ranbaxy.

Source: Wikipedia

Estimated Total Cost: $37.27 for an average of 7 days supply

What is it prescribed for?

Patients are most commonly prescribed cefdinir to treat otitis media, nasal congestion, ear pain, and chronic sinusitis.

What drug interactions are known?

Do not take cefdinir if you are taking any of the following:

Critical Interactions

Significant Interactions

Ajax-loader Loading...